Deep diving in the PACIFIC: Practical issues in stage III non-small cell lung cancer to avoid shipwreck

After publication of the PACIFIC trial results, immune checkpoint inhibitor-based immunotherapy was included in the treatment algorithm of locally advanced non-small cell lung cancer (NSCLC). The PACIFIC trial demonstrated that 12 mo of durvalumab consolidation therapy after radical-intent platinum...

Descripción completa

Detalles Bibliográficos
Autores principales: Mielgo-Rubio, Xabier, Rojo, Federico, Mezquita-Pérez, Laura, Casas, Francesc, Wals, Amadeo, Juan, Manel, Aguado, Carlos, Garde-Noguera, Javier, Vicente, David, Couñago, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701908/
https://www.ncbi.nlm.nih.gov/pubmed/33312885
http://dx.doi.org/10.5306/wjco.v11.i11.898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701908/
https://www.ncbi.nlm.nih.gov/pubmed/33312885
http://dx.doi.org/10.5306/wjco.v11.i11.898

Ejemplares similares